Evinova found that 50% fewer patients were needed in a Phase II COPD study compared to a traditional design.
Published
Signal category
Research & Knowledge
Quote
“50% fewer patients needed (288 vs. 604 in a traditional design)”
— Evinova team
Company
Evinova
Global healthtech
- Industry
- Software Development
- Company size
- 428 employees
Digital solutions need to do more to propel clinical development, elevate user experiences and accelerate better health outcomes. At Evinova, we’re doing something about it. We’re a healthtech business, with globally-scaled digital products that have proven benefits for sponsors, sites and patients. We've accelerated timelines, improved patient experiences, reduced costs, and minimised carbon footprints across hundreds of clinical studies. Evinova is a 300+ person strong team offering digital solutions to pharma, biotech and CROs to support clinical research globally. Community Guidelines: http://bit.ly/3JIeErQ
Founded 2023